Sensorineural Hearing Loss and the Diagnosis of Acoustic Neuroma by Monsell, Edwin M. & Rock, Jack P.
Henry Ford Hospital Medical Journal 
Volume 38 Number 1 Article 3 
3-1990 
Sensorineural Hearing Loss and the Diagnosis of Acoustic 
Neuroma 
Edwin M. Monsell 
Jack P. Rock 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Monsell, Edwin M. and Rock, Jack P. (1990) "Sensorineural Hearing Loss and the Diagnosis of Acoustic 
Neuroma," Henry Ford Hospital Medical Journal : Vol. 38 : No. 1 , 9-12. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol38/iss1/3 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
Sensorineural Hearing Loss and the Diagnosis of Acoustic Neuroma 
Edwin M. Monsell, MD, PhD,* and Jack P. Rock, MD' 
Sensorineural hearing loss and tinnitus are gradually receiving more attention in medicine due to 
advances in diagnosis and treatment. Acoustic neuromas can now be detected when they are small, 
and early microsurgical removal results in the lowest overall morbidity. We examine the historical 
development of acoustic neuroma management, discuss current diagnosis and treaiment, and present 
illustrative cases from our receni experience. Complaints of tinnitus and hearing loss, especially 
when unilateral, require appropriate medical evaluation. (Henry Ford Hosp Med J 1990:38:9-12) 
I n the past hearing loss and tinnitus were often regarded as mi-nor nuisances not merifing medical attention. This neglectful 
attitude originated from the once common view that hearing toss 
was a hopeless or comical condition and was indicafive of soci-
ety's prejudice against the aged and the hearing impaired. More-
over, littie could be done for hearing-impaired individuals unfil 
the introduction of Lempert's one-stage fenestration procedure 
just prior to World War It and the development and refinement 
of stapes surgery, tympanoplasty, and hearing aids in the first 
two decades after the war. Today hearing toss, tike the loss of 
any sensory function, is more widely recognized as a medical 
symptom which requires evaluation and which does not in itself 
consfitute a diagnosis. 
Historical Perspective on Tumor Treatment 
At the tum ofthe century, intracranial surgery uniformly re-
sulted in fatality. Patients who did not die from hemorrhage suc-
cumbed to .sepsis. Despite this grim prognosis, surgical treat-
ment of acoustic neuromas was sometimes attempted when pa-
tients became bedridden by severe cerebellar ataxia, lapsing in 
to and out of obtundation from brain stem compression and in-
tracranial hypertension. If a patient presented with hearing loss, 
headache, and papilledema, the diagnosis of intracranial tumor 
was considered to be established. If the patient were atso ataxic, 
the tumor was presumed to be in the posterior cranial fossa (1). 
Boston neurosurgeon Harvey Gushing made significant eariy 
contributions to the diagnosis and treatment of acoustic neuro-
mas, Cushing's first successful treatment consisted of removing 
the suboccipital bone bilaterally, allowing for expansion of the 
intracranial contents. This procedure allowed most pafients to 
become ambulatory and protonged their life by a few months. 
Later, Gushing succeeded with the subtotal removal of tumors. 
Operative mortality was reduced to 25%, a great achievement at 
that time, Cushing's careful accumularion of patient histories 
and physical findings led to the first detailed account of the clin-
ical course and natural history of acousfic tumors. He described 
several surgical approaches to the cerebellopontine angle that 
are still in use today (2,3). 
Cushing's pupil, Walter Dandy, not as keen a clinical observ-
er as Gushing though he had remarkable technical skill, was the 
first to carry out complete removal of tumors consistently. His 
lifetime operative mortality was 22.1%, and in one remarkable 
series toward the end of his career, operative mortality was 2.4% 
(4). 
In 1949 the importance of the anterior inferior cerebellar ar-
tery as a vital stmcture was recognized (5). Sparing this stmc-
ture reduced operative mortality further. 
In 1964 William House, an otologist working with neurosur-
geon William Hitselberger, published his series of 53 tumors re-
moved through a transtemporal bone microsurgical approach, 
called the translabyrinthine approach (6). House and coworkers 
have since removed more than 2,700 tumors with operative 
mortality below 0.5%. Moreover, facial nerve function was pre-
served in the majority of cases and other neurologic deficits 
were rare (6,7). 
These results were achieved because the facial nerve can be 
identified lateral to the tumor with the surgical microscope us-
ing secure bony landmarks. The nerve can then be followed me-
dially to the tumor white the plane of separation between nerve 
and tumor is maintained. Manipulation of the brain stem and 
cerebellum is minimized, resulting in fewer intracranial compli-
cations. Pafients are operated upon in the supine position, which 
avoids the rare complication of quadriplegia and the more com-
mon, potentially fatal, venous air emboli sm that can occur when 
the pafient is operated upon in a sitting position (8). 
Other surgical approaches continue to be useful, including the 
middle fossa approach described by House, which permits the 
removal of small tumors and preserves hearing. The combined 
approach, described by Gushing and popularized in the contem-
porary era by Glasscock (8), combines the advantages of the 
translabyrinthine and suboccipital approaches. Surgical ap-
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proaches and techniques confinue to evolve. Most centers offer 
a team approach combining the skills of an otologist, neurosur-
geon, neuroanesthesiotogist, and neurophysiologist. The use of 
perioperative antibiotics, continuous arterial pressure monitor-
ing, pulse oximetry, neuroanesthesia, intensive care units, and 
intraoperative facial nerve monitoring have improved the out-
come of acoustic tumor surgery. Current operative mortality is 
in the range of 0.5% in most series. 
Ttimor Diagnosis 
Improvements in surgical techniques have been matched by 
improvements in diagnostic techniques. Audiology has devel-
oped rapidly as a clinical discipline since the 1940s. It is now 
possible to measure hearing pure tone air and bone conduction 
thresholds, speech reception thresholds, and speech discrimina-
tion. The introduction of the measurement of acoustic imped-
ance has added the ability to determine the threshold and decay 
properties of the acoustic reflex (9). Auditory brain stem re-
sponse (ABR) testing determines the integrity of the auditory 
nerve. The ABR is an auditory-evoked response and the most 
cost-effecfive screening test available for acoustic neuroma and 
other disorders of the auditory nerve (10). Its main limitafion is 
its dependence on intact hearing. Test subjects must have hear-
ing at the 60 to 70 dB tevel or better in the high frequency range 
of 3,000 to 4,000 Hz; otherwise the recording may be uninter-
pretable. The sensitivity of the test depends on the magnitude of 
the normal range, which is defined statistically and is generally 
in the range of 98%. For this reason, ABR is best used in the con-
text of the ful l neurotologic evaluation. 
Imaging techniques were once limited to skull radiography 
that showed the outiine of the intemal auditory canals (lAGs). 
The IAG is usually widened in medium to large acoustic neuro-
mas. Complex motion tomography combined with the introduc-
tion of radiographic contrast material into the subarachnoid 
space allowed tumor detecrion and estimation of tumor size 
and boundaries. Computed tomography (CT) with intravenous 
radiographic contrast and air contrast in the cerebellopontine an-
gle represented an advance that made early routine detection of 
even small tumors possible for the first time. Magnetic reso-
nance imaging (MRI) with gadolinium contrast has become the 
"gold standard" diagnostic test for acoustic neuroma. This 
method is able to detect tumors as small as 2 to 3 mm and is the 
most accurate in determining tumor boundaries at any size. The 
history of acoustic neuroma diagnosis and the history of treat-
ment are linked; as treatment has improved, the imperative for 
early diagnosis has grown. 
Clinical Characteristics 
Histologically, acoustic neuromas are benign tumors of the 
Schwann cefi sheath of the eighth cranial nerve. They grow 
slowly but continuously and, i f untreated, are eventually fatal in 
most cases. Regardless of the surgical technique used, risks and 
complications are fewer i f tumors are removed when small. 
Now that early tumor detection is possibte and the advantages of 
eariy diagnosis are well appreciated, there is a compelling need 
to pursue this diagnosis. 
Gushing showed that the earliest sign of acoustic neuroma is 
hearing loss. Today asymmetric hearing loss is still recognized 
as the most prevalent sign on presentarion, although patients 
may present with other symptoms (11). 
Hearing Loss 
Sensorineural hearing loss is prevalent in approximately 
10% ofthe population, with the risk increasing to 20% by age 65 
years. While the hearing loss rate of 2 to 3 dB/year after age 65 
years may be a part of the normal aging process (presbycusis), 
an asymmetric sensorineural hearing loss at any age should be 
considered the result of an acoustic neuroma until proved oth-
erwise. Moreover, tumors may present with dysequUibrium, 
numbness ofthe face, aural fullness, tinnitus, or aural pain. They 
may be detected as incidental findings in asymptomatic pa-
tients. The incidence of acoustic neuroma has been estimated to 
be 0.8 to 1.0 per 100,000 population per year. 
Case Presentations 
Casel 
This healthy 16-year-old boy was sitting on his front porch when he 
noticed a ringing sound in his left ear and suddenly lost all hearing in 
the ear. He had no vestibular symptoms. He sought medical attention 
and was referred lo an otolaryngologist. Physical examination revealed 
the ears, head, and neck to be normal. Audiometric evaluation revealed 
a profound sensorineural hearing loss on the left. CT demonstrated a 
soft tissue mass filling the intemal auditory canal and extending 1 cm 
medial to the porous acusticus. He was referred to Henry Ford Hospital. 
A 1 cm tumor was removed via the translabyrinthine route in a com-
bined neurotologic and neurosurgical procedure. Facial nerve function 
was normal postoperatively. Histopathologic examination ofthe tumor 
specimen established the diagnosis of schwannoma (acoustic neuro-
ma). An organized hematoma was found in the tumor specimen. The 
patient's recovery was uneventful. 
Comments 
This case illustrates the occurrence of acoustic neuroma presenting 
as sudden sensorineural hearing loss. The presence of an old hematoma 
suggests that the sudden loss of hearing may have been caused by sud-
den bleeding into the tumor. It has been established that acoustic neuro-
ma may present as sudden hearing loss and that hearing may recover 
even in the presence of a tumor (12). 
Case 2 
This 38-year-old woman presented to her otolaryngologist with a 
three-year history of intermittent mild dysequilibrium and a nine-
month history of mild left hearing loss. Physical examination was un-
remarkable. Audiometric evaluation revealed mild left sensorineural 
hearing loss and normal acoustic reflexes. An auditory-evoked poten-
tial study revealed abnormality on the left side. CT showed mild wid-
ening of the left intemal auditory canal. A faint shadow suggested the 
possibility of a mass in the cerebellopontine angle. The patient was re-
ferred to Henry Ford Hospital. 
MRI with gadolinium enhancement demonstrated an enhancing 
mass extending from the fundus of the intemal auditory canal to the 
brain stem. The tumor was removed via the translabyrinthine route in a 
combined neurotologic and neurosurgical procedure. Facial nerve 
function was normal postoperatively. Histopathologic examinalion 
confirmed the diagnosis of acoustic neuroma. The patient's recovery 
was uneventful. 
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Figure—Small left intracanaticular acoustic neuroma similar to that of case 3; left) axial and right) coronal section by MRI. 
Comments 
This case illustrates the presentalion of acoustic neuroma with mild 
hearing loss. Hearing preservation was not attempted because the tu-
mor filled the internal auditory canal and extended to its fundus. CT 
only suggested the presence of a tumor, which was confirmed by MRI 
with gadolinium enhancement. 
Case 3 
This 26-year-old man presenied wilh a one-year hislory of fluctuat-
ing hearing loss and aural fullness without vestibular symptoms. 
Audiometric evaluation showed a mild righl sensorineural hearing loss. 
Subsequent evaluations demonstrated normal hearing. MRI with gado-
linium enhancement showed a tumor in the intemal auditory canal, ex-
tending 0.5 cm loward the brain stem. The acoustic neuroma was re-
moved through the suboccipital approach with electrophysiologic 
monitoring of both auditory and facial nerves. Intraoperatively, the tu-
mor was noted to be tightly adherent to the auditory nerve withoul a 
clear plane of separation. Postoperative hearing remained normal 
through 1,000 Hz but dropped precipitously at higher frequencies (Fig-
ure). Postoperative speech discrimination was 60% and facial nerve 
function was normal. 
Comments 
This case illustrates that mild hearing loss usually associated with 
relatively small tumors may fluctuate and could even presenl as nor-
mal. Even a hisloiy of hearing loss should be persued, despite initially 
negative findings. Hearing preservation is possible in some cases. 
Case 4 
This 60-year-old woman was followed for several years because of 
hearing loss and episodic vertigo which were thought to be caused by 
Meniere's disease. She soughl a second opinion al Henry Ford Hospi-
tal. Audiometric evaluation showed severe bilateral sensorineural hear-
ing loss, with hearing better on the righl side. CT showed a 3 cm tumor 
in the right cerebellopontine angle. The acoustic neuroma was removed 
through the translabyrinthine approach. Postoperatively facial nerve 
function was normal, andthe patient's recovery was uneventful. She 
was referred for auditory rehabilitation. 
Comments 
This case illustrates that acoustic neuromas can mimic classical 
Meniere's disea.se. Whereas this patient had episodic vertigo of the Me-
niere type, case 3 showed fluctuating hearing in the manner of early 
Meniere's disease. Acoustic neuroma should be excluded in patients 
with episodic vertigo, tinnitus, and hearing loss before that clinical syn-
drome is accepted as diagnostic of Meniere's disease. 
Discussion 
We are in a new era in tumor management and in the man-
agement of sensorineural hearing loss. Tumors can be diag-
nosed when small, and operative complications are fewer if sur-
gery is performed when tumors are small (13). Tumors present 
with common, seemingly minor symptoms, such as sensorineu-
ral hearing loss. Whereas tumors are rare, sensorineural hearing 
loss is common. 
While it might be desirable for everyone with mild ear symp-
toms to undergo M R I , health care resources are limited and 
scans are expensive. Unfortunately, we have no uniformly ac-
cepted standard method to detect the rare acoustic tumors 
among the common cases of sensorineural hearing loss. Devel-
opment of such a standard would need to take into account a 
monetary estimate of the "cost" of the morbidity added by delay 
in diagnosis. The costs of tests vary between institutions as does 
the rate of surgical complications. Tumor growth rates are un-
predictably variable across individuals and over time for the 
same individual. 
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We recommend that patients be screened with air, bone, 
speech, and impedance audiometry. Patients with asymmetric 
hearing, asymmetric speech discrimination, or afferent limb 
acoustic reflex abnormalities should be evaluated further (9,14). 
We believe that the possibility of acoustic neuroma should be 
considered in atl patients with asymmetric sensorineural hear-
ing toss or with other persistent unilateral or asymmetric ear 
symptoms. A tess aggressive approach can be taken in asympto-
matic patients who are permanently debilitated or over age 65 
years. 
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